Most Up-to Date Report on the Us Specialty Pharmaceutical Market Report 2015

ResearchMoz.us include new market research report " The US Specialty Pharmaceutical Market Report 2015 Edition: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control monitoring. These products are often manufactured for small populations of people suffering from somewhat rare, life-threatening and debilitating diseases. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.

View report details with TOC at: http://www.researchmoz.us/the-us-specialty-pharmaceutical-market-report-2015-edition-report.html

Currently, specialty drugs are one of the fastest growing segments of the overall pharmaceutical market, as sales growth is being driven by improved efficacy compared with currently marketed therapies, while expanded indications for already marketed drugs and off label prescribing can drive sales of these drugs by increasing potential patient populations. The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Apart from these growth drivers, many challenges lie ahead for the specialty pharmaceutical market in the US, including the changes in reimbursement process due to healthcare reforms, regulatory pressures, narrowing specialty pharmacy networks and lack of access to specialty pharmacy products.

Some of the noteworthy trends and developments of this industry include novel specialty product launches, growing Hepatitis-C segment, increased spending on specialty drugs and ongoing merger & acquisition activities. The percentage of specialty pharmaceuticals sales of the overall US...